NASDAQ
DOX
Last Price
US $50.54
KEY FIGURES
MKT CAP
$5.6B
EPS
TTM
$5.10
PEG
TTM
1.82x
P/E
TTM
10.33x
P/S
TTM
1.23x
YIELD
4.14%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
15.91%
Return on equity
ROIC: 12.71%
Valuation History
10.3X
Price to Earnings
EV/EBITDA: 6.8X
Cash flow
Profit margin
1.69%
(FY vs FY)
EBITDA Y/Y
3.20%
(FY vs FY)
Cash flow Y/Y
7.35%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $50.54
79.22%
Default assumptions
EBITDA Multiple
Fair Value
Market $50.54
9.77%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Amdocs Limited cash flow to debt ratio of 90.65% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.
Financial stability - Healthy cash flow growth.
Amdocs Limited's free cash flow has increased 4.23% from $618.93M last year to $645.14M, signaling increasing performance
Financial stability - Healthy debt to equity ratio.
Amdocs Limited's debt to equity ratio is 0.32, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial risk - Healthy debt to equity ratio development.
Amdocs Limited's debt has increased relative to shareholder equity from 0.23 last year to 0.32 today, signaling weakened financials
Financial stability - Net debt/EBITDA.
Amdocs Limited has a net debt to EBITDA ratio of 0.54x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Amdocs Limited's interest coverage ratio of 27.36 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Amdocs Limited's profit margin has increased (19.97%) in the last year from 9.85% to 11.82%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Amdocs Limited's short-term assets of $1.59G exceed its short-term liabilities of $1.36G
Increasing performance - ROA.
Amdocs Limited's return on assets of 8.59% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Amdocs Limited's return on equity of 15.91%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Amdocs Limited's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Amdocs Limited had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Amdocs Limited has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Amdocs Limited has a free cash flow yield of 11.54%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Amdocs Limited's yearly earnings has increased 14.50% since last year from $493.20M to $564.70M, signaling increasing performance
Decreasing performance - Healthy revenue growth.
Amdocs Limited's yearly revenue has decreased -9.43% since last year from $5.00G to $4.53G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 12.71% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
Amdocs Limited's 3-year revenue CAGR of -0.32% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Amdocs Limited had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Amdocs Limited had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
Amdocs Limited is undervalued relative to its fair value price of 90.58 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Amdocs Limited has an earnings yield of 9.82%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Undervalued - EBITDA valuation.
Amdocs Limited is undervalued relative to its fair value price of 55.48 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Amdocs Limited has an EV/EBITDA ratio of 6.84x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Amdocs Limited has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
Amdocs Limited has a price-to-book ratio of 1.65x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Amdocs Limited has a price-to-sales ratio of 1.21x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue